Geode Capital Management LLC raised its position in shares of Maximus, Inc. (NYSE:MMS) by 6.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 496,870 shares of the health services provider’s stock after buying an additional 31,918 shares during the period. Geode Capital Management LLC owned 0.77% of Maximus worth $30,905,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Neuburgh Advisers LLC increased its position in Maximus by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock worth $105,000 after buying an additional 32 shares during the period. Acrospire Investment Management LLC increased its position in Maximus by 183.3% in the first quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock worth $106,000 after buying an additional 1,100 shares during the period. Glen Harbor Capital Management LLC increased its position in Maximus by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock worth $145,000 after buying an additional 44 shares during the period. Elkfork Partners LLC increased its position in Maximus by 1.9% in the first quarter. Elkfork Partners LLC now owns 2,968 shares of the health services provider’s stock worth $185,000 after buying an additional 56 shares during the period. Finally, Violich Capital Management Inc. acquired a new position in Maximus during the first quarter worth $217,000. 97.89% of the stock is owned by institutional investors and hedge funds.
Maximus, Inc. (NYSE:MMS) traded up 0.25% during mid-day trading on Friday, hitting $60.41. 220,638 shares of the stock were exchanged. Maximus, Inc. has a 52 week low of $43.69 and a 52 week high of $64.97. The stock’s 50-day moving average is $62.10 and its 200 day moving average is $60.64. The company has a market capitalization of $3.92 billion, a PE ratio of 19.81 and a beta of 1.40.
Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, May 4th. The health services provider reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.02. The business had revenue of $622 million for the quarter, compared to the consensus estimate of $620.24 million. Maximus had a net margin of 8.18% and a return on equity of 26.21%. The company’s revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.74 earnings per share. On average, analysts anticipate that Maximus, Inc. will post $3.05 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th will be issued a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 0.30%. The ex-dividend date is Friday, August 11th. Maximus’s dividend payout ratio (DPR) is presently 5.86%.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2017/07/30/geode-capital-management-llc-buys-31918-shares-of-maximus-inc-nysemms-updated-updated-updated.html.
A number of research analysts recently weighed in on the stock. BidaskClub downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. ValuEngine cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. KeyCorp reiterated a “sector weight” rating on shares of Maximus in a research note on Thursday, May 25th. Zacks Investment Research upgraded shares of Maximus from a “sell” rating to a “hold” rating in a research note on Wednesday. Finally, Jefferies Group LLC cut shares of Maximus from a “buy” rating to a “hold” rating and increased their price target for the company from $63.00 to $64.00 in a research note on Friday, May 5th. One investment analyst has rated the stock with a sell rating and eight have issued a hold rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $61.00.
In other news, General Counsel David Francis sold 1,000 shares of the stock in a transaction dated Friday, July 14th. The shares were sold at an average price of $60.46, for a total value of $60,460.00. Following the sale, the general counsel now directly owns 15,715 shares of the company’s stock, valued at $950,128.90. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Richard A. Montoni sold 30,000 shares of the stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $62.81, for a total transaction of $1,884,300.00. Following the completion of the sale, the chief executive officer now directly owns 584,114 shares in the company, valued at $36,688,200.34. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 109,846 shares of company stock worth $6,893,986. Insiders own 3.10% of the company’s stock.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.